# Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

> **NCT00438477** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 74 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Isosulfan Blue
- **PROCEDURE:** Lymphangiography
- **RADIATION:** Technetium Tc 99m sulfur colloid

## Key facts

- **NCT ID:** NCT00438477
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-08
- **Final completion:** 2008-04
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438477, "Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00438477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*